Retatrutide (Triple G) - 90 Day (Subscription)

90 Days - Available Nationwide! Triple G (Retatrutide) is the latest compound that’s pushing the boundaries of obesity treatment. Triple G targets three receptors—GLP-1, GIP, and GCG—each playing a distinct role in metabolism. GLP-1 reduces appetite, GIP enhances fat clearance, and GCG boosts energy expenditure, potentially increasing your metabolic rate. This unique triple-action mechanism sets Triple G apart from drugs like semaglutide (Wegovy) or tirzepatide (Zepbound). Published in the New England Journal of Medicine, Phase 2 trial results showed participants on the 12 mg dose achieved an average 24.2% body weight reduction (about 60 pounds) after 48 weeks. Approximately 25% of participants lost 30% or more of their weight. Compared to semaglutide and tirzepatide, Triple G appears to produce faster and more substantial weight loss, with a side effect profile that’s generally comparable.  Micro Dosing Instructions: 16mg/ml Vial (2ml): Inject 5 units (0.05 ml, 0.8 mg) three times wee